



A 56-year-old earning $198,000 weighs financial independence against private healthcare premiums. The calculation reveals why even six-figure salaries struggle with early retirement planning.

Mixing friendship with financial advice can lead to devastating losses and broken relationships. Here's how to protect your money and your social circle.

Akeso and Summit's ivonescimab delivers 34% death risk reduction in Phase 3 trials. Western pharmaceutical giants face unprecedented Asian competition in oncology markets worth tens of billions.

U.S. Treasury has advanced plans for a new $250 commemorative note featuring Trump, but a century-old statute may block issuance.

Technology giants' insatiable appetite for electricity creates unprecedented profit opportunities for regulated utilities. Market analysts warn the logical next step could reshape America's power infrastructure entirely.

Investment vehicles offering SpaceX exposure emerge ahead of anticipated public offering. Market observers expect significant retail demand when Musk's space venture eventually goes public.

Gap and American Eagle shares plummet after disappointing earnings, yet both companies insist broader economy remains healthy. Market skepticism grows over retail leadership messaging disconnect.

May witnessed the steepest monthly crude decline since 2020 as diplomatic breakthrough expectations flood markets with optimism. Western consumers face immediate relief at the pump while energy investors recalibrate geopolitical risk premiums.